Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3151 results found

2024 ∙ Wu, X. Xu, K. Zhan, P. Liu, H. Zhang, F. Song, Y. Lv, T.

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Omidi, F. Rahmannia, M. Khalili, F. Shahidi Bonjar, A. H. Nasiri, M. J.

Comparing higher-dose and single standard-dose influenza vaccines in preventing cardiovascular events: a meta-analysis with 68,713 patients

  • All age groups
  • Influenza
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ San Francisco Ramos, A. Liu Sanchez, C. Bovill Rose, T. Smith, D. Thorn, N. Galiza, E. Miah, T. Pearce, J. Hultin, C. Cosgrove, C. Hsia, Y. Heath, P. T.

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Zeng, Y. Du, Z. Shao, C. Zhao, M.

Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Chamani, I. J. Taylor, L. L. Dadoun, S. E. McKenzie, L. J. Detti, L. Ouellette, L. McCulloh, D. H. Licciardi, F. L.

Coronavirus Disease 2019 (COVID-19) Vaccination and Assisted Reproduction Outcomes: A Systematic Review and Meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Gharpure, R. Chard, A. N. Cabrera Escobar, M. Zhou, W. Valleau, M. M. Yau, T. S. Bresee, J. S. Azziz-Baumgartner, E. Pallas, S. W. Lafond, K. E.

Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022

  • Children
  • Older adults
  • Pregnant women
  • Low and Middle Income Countries
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Slavkovsky, R. Callen, E. Pecenka, C. Mvundura, M.

Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review

  • Children
  • Adolescents
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Economic aspects
  • Logistics
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Alemu, T. G. Tamir, T. T. Workneh, B. S. Mekonen, E. G. Ali, M. S. Zegeye, A. F. Wassie, M. Kassie, A. T. Tekeba, B. Gonete, A. T.

Coverage and determinants of second-dose measles vaccination among under-five children in East Africa countries: a systematic review and meta-analysis

  • Africa
  • Children
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Zhang, Q. Jiao, L. Chen, Q. Bulstra, C. A. Geldsetzer, P. de Oliveira, T. Yang, J. Wang, C. Barnighausen, T. Chen, S.

COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Yeo, S. Z. J. Ho, C. L.

COVID-19 mRNA vaccine-related myocarditis: A PRISMA systematic review, imaging approach and differential diagnoses

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...